Episode 22 - IL13R antagonist for chronic itch developed in Singapore; and a chat with Prof Tan Suat Hoon

<p>Sashen and I discuss Eblasakimab, a new-in-class biologic agent that may potentially address chronic itch in atopic dermatitis. Then I speak with Prof Tan Suat Hoon, Director of the National Skin Centre, about lessons learnt from the pandemic, and the upcoming New Building for NSC, and future of dermatology clinical care in Singapore.</p><p>Online registration for the WCD 2023 is now open! <a href="https://www.wcd2023singapore.org/registration/">https://www.wcd2023singapore.org/registration/</a> </p><p>And we are also accepting abstract submissions: <a href="https://www.wcd2023singapore.org/scientific-programme/abstract-submission/">https://www.wcd2023singapore.org/scientific-programme/abstract-submission/</a></p>